NCT03880682View on ClinicalTrials.gov

Direct Acting Antivirals for HCV Infection in Kidney Transplant Recipients

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

June 15, 2019

Study Completion Date

October 31, 2019

Conditions
Kidney Transplant; ComplicationsHepatitis C, Chronic
Trial Locations (1)

Unknown

Istanbul University, Istanbul

All Listed Sponsors
lead

Istanbul University

OTHER

NCT03880682 - Direct Acting Antivirals for HCV Infection in Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter